AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2015
Nov 16, 2015
29745_dirs_2015-11-16_0c373777-d131-4214-8c16-755eb44b5c8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-11-12
Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-12 | Common Stock | M | 6928 | $56.18 | Acquired | 118710 | Direct |
| 2015-11-12 | Common Stock | F | 5579 | $80.70 | Disposed | 113131 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-12 | Employee stock option 2/06 (right to buy) | $56.18 | M | 6928 | Disposed | 2016-02-09 | Common Stock (6928.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4763 | Indirect |
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29